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20. The comparison of the results with the patients who had a GRWR ≥0.8 has
shown no significant difference but MELD-score and BMI, which were both
significantly higher.
Conclusion: Based on the results of our study, we conclude that the GRWR
can be reduced safely even to 0.6 in patients with low MELD-score. More




(n = 403) p-Value
Age (mean) 51 years 50 years 0.9
BMI (mean) 29 26 0.0001*
MELD-score (mean) 14 19 0.01*
Hospital stay (mean) 18 days 20 days 0.4
Postop. complications 10 (23%) 128 (31%) 0.2
Periop. mortality 3 (7%) 40 (9%) 0.8
Re-Transplantation 1 (2%) 11 (2%) 1.0
One-year-survival 93% 91% 0.5
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Introduction: Donation after circulatory death (DCD) have been proposed to
partially overcome the organ donor shortage. DCD-LT remains controversial,
with reported increased risk of graft loss and retransplantation. The authors
retrospectively reviewed a single centre experience with controlled DCD-LT in
a 12-year period.
Patients and Methods: 100 DCD-LT were consecutively performed between
2003 and 2014. All donation and procurement procedures were performed as
controlled DCD in operative rooms. Data are presented as median (ranges).
Median donor age was 57 years (16–83). Median DRI was 2.16 (1.4–3.4). Most
grafts were flushed with HTK solution. Allocation was centre-based. Median
recipient MELD score at LT was 15 (7–40). Mean follow-up was 35 months. No
patient was lost to follow-up.
Results: Median total DCD warm ischemia was 19 min (10–39). Median cold
ischemia was 235 min (113–576). Median peak AST was 1132 U/l (282–
21 928). Median peak bilirubin was 28 mg/dL. Patient survivals were 90.7%,
75.5% and 70.7% at 1.3 and 5 years, respectively. Graft survivals were 88.7%,
72.1% and 67.1% at 1.3 and 5 years, respectively. Biliary complications
included mainly anastomotic strictures and extrahepatic main bile duct
ischemic obstruction, that were managed either by endoscopy or hepatico-
jejunostomy. No PNF or graft loss due to ischemic cholangiopathy was
observed in this series.
Discussion: In this series, DCD LT appears to provide results similar to
classical LT. Short cold ischemia and recipient selection with low MELD score
may be the keys to good results in DCD LT, in terms of graft survival and
avoidance of ischemic cholangiopathy. If symptomatic ischemic cholangiopa-
thy is diagnosed, adequate management with endoscopy and surgical
hepaticojejunostomy may avoid graft loss and retransplantation.
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Reconstruction of anterior sector (AS) drainage veins using interposition
homologous or prosthetic grafts has been an established technique in right lobe
(RL) living donor liver transplantation (LDLT). Material of choice used for this
type of reconstruction have been cryopreserved homologous grafts, because
of lower patency rates reported for prosthetic grafts. However, with relative
shortage of cryopreserved grafts, prosthetic grafts have the advantage of their
unlimited availability. This study investigates short-term patency rate of
polyester (Dacron!) grafts used as venous conduit for AS drainage of RL
grafts.
Between January 2014 and December 2014, 51 of 80 (63%) patients who
underwent LDLT in our institution received a RL graft with AS venous
reconstruction including isolated segment 5 (n = 5), isolated segment 8
(n = 6), or combined segment 5 and 8 (n = 40) drainage. A separate accessory
inferior right hepatic vein reconstruction was also performed in 16 (31%)
patients. All reconstructions were performed using Dacron grafts.
Dacron graft patency was investigated in 75% (n = 38) of the patients using
either Doppler ultrasound (n = 25) or computed tomography (n = 29). Dacron
graft was patent in 32 of 38 patients (84.2%) in a median time of 37 (10.0–97.5)
days after LDLT. In 6 patients with AS venous outflow obstruction, no
significant clinical consequence was observed. There was 1 perioperative
mortality due to sepsis and 1 graft loss due to initial poor function, which needed
retransplantation. In a median follow-up of 7 (5–10) months, 49/51 (96%)
patients were alive. Dacron grafts have high short-term patency rates
comparable to those of cryopreserved homologous grafts; thus, they offer an
excellent source of interposition material for reconstruction of AS drainage
veins in RL LDLT.
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Background: Transplantation of liver grafts from donors after circulatory
death (DCD) is now an accepted practice with equivalent outcomes when
compared with standard deceased brain dead (DBD) donors. The outcomes of
patients transplanted in the setting of hepatocellular cancer (HCC) with DCD
versus DBD still remain controversial due to questionable poorer outcomes
with DCD donors. However, prior studies have focused only on overall survival
and ignored the impact of recurrence on survival.
Methods: A multicenter review of a combined HCC database (Ochsner
Medical Center and Toronto General Hospital) was performed from 1/2008 to
12/2013.
Results: 385 patients (41 DCD and 344 DBD) were identified and included in
the analysis. There were 49 recurrences (14%) in the DBD group versus 6
recurrences (14%) in the DCD group (p = 0.946). The recurrence-free survival
was equivalent for the DCD versus DBD groups (p = 0.819). Similarly, overall
1/3 year survival was 94%/85% and 92%/83% for the DBD versus the DCD
groups, respectively. In multivariate regression analysis, lymphovascular
invasion, tumor number (>5), and tumor size (>5 cm) were shown to be
significant predictors of tumor recurrence not donor type.
Conclusion: DCD liver transplants when performed in experienced centers
yield equivalent oncologic outcomes for patients transplanted with HCC.
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Objectives: Traditionally Roux-en-Y hepaticojujenostomywas the method of
choice for biliary reconstruction in primary sclerosingchollangitis (PSC) in
patients undergoing orthotopic liver transplantation. In this study, we compared
the result of duct to duct anastomosis versus Roux-en-Y hepaticojujenostomy
as biliary reconstruction in patients with primary sclerosingchollangitis who
underwent liver transplant in Shiraz organ transplant center.
Methodsand Materials: There were 69 patients with primary sclerosingchol-
langitis who underwent liver transplant. Mean follow up period was
36.5 months (18–55 months). We performed duct to duct reconstruction in
those patients who had grossly normal bile duct during hepatectomy. In 29
cases duct to duct reconstruction was done and Roux-en-Y hepaticojujenos-
tomy reconstruction in 40 cases. Data collecting form contained biliary
complications (leak, stricture, and cancer in the remnant bile duct), docu-
mented episodes of rejection, and morbidity.
Results: In duct to duct group, two patients presented with anastomotic site
stricture and one patient developed chollangiocarcinoma in distal bile duct
which underwent pancreaticoduodenectomy (3/29). In Roux-en-Y group, five
patients developed anastomotic stricture in the follow up (5/40). This difference
was not significant (p value = 0.999). Also documented episodes of rejection
were similar between two groups (Chi square test, p value = 0.66) and there
was no significant difference.
Discussion: We concluded that duct to duct reconstruction is safe andmaybe
the choice method for biliary reconstruction in some patients with PSC. In
addition, due to innovations in ERCP, management of strictures in duct to duct
group was more easy and feasible in comparison to revision of Roux-en-Y
hepaticojujenostomy
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